Tatia Global Vennture Limited: Civil Suit Withdrawn, Company Complies with Regulatory Disclosure

Tatia Global Vennture Limited, a company listed on the Bombay Stock Exchange (BSE: 521228), has reported the withdrawal of a civil suit filed against it by a client, Dr. Karikkassery Thomas Joseph Rajan. The company disclosed this information in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Details of the Civil Suit

The civil suit, numbered C.S. No. 156 of 2024, was filed before the High Court of Judicature. The plaintiff, Dr. Karikkassery Thomas Joseph Rajan, had sought the following reliefs:

1. A direction for the company to pay a sum of Rs. 1,15,23,008.00
2. Interest at 18% per annum on the above amount from the date of filing the plaint until the date of decree, and thereafter at the same rate until realization
3. Payment of legal costs associated with the suit

Withdrawal and Dismissal

According to the company's disclosure, the plaintiff sought permission from the court to withdraw the suit. Consequently, the High Court of Judicature passed an order on June 26, 2025, dismissing the case as withdrawn.

Regulatory Compliance

Tatia Global Vennture Limited demonstrated its commitment to regulatory compliance by adhering to the following timeline:

In its communication to the BSE, the company emphasized that there was no delay in submitting the disclosure to the exchange, as it was done within the stipulated 24-hour timeframe.

Company's Statement

Madhur Agarwal, Company Secretary and Compliance Officer of Tatia Global Vennture Limited, signed the regulatory filing, confirming the details of the case withdrawal and the company's timely disclosure.

This development marks the resolution of a potential legal challenge for Tatia Global Vennture Limited, with the withdrawal of the civil suit alleviating concerns about the claimed financial liability and associated legal proceedings.